With dozens of recently released revised clinical guidelines, breakthrough trial data, and newly approved drugs on the market, it is increasingly important for clinicians leading the fight against cardiometabolic disease to review the latest topics and industry developments. Explore how the most respected leaders of the industry are advancing cardiometabolic health and combating the growing epidemic of cardiovascular diseases through sessions spotlighting the most recent and relevant research.
The incidence of heart failure is the only form of heart disease that has not decreased in over 30 years, with approximately 550,000 new cases diagnosed in the U.S. per year. Technological advancements in cardiac devices and improved prevention and treatment methods have diminished the death rate, but cardiovascular disease remains the leading cause of death in the country. A growing need to identify the underlying metabolic causes of heart failure has prompted new studies aimed at developing new therapies for patients and addressing the problem at its earliest stage.